🇺🇸 FDA
Patent

US 7524490

Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site

granted A61KA61K38/1709

Quick answer

US patent 7524490 (Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site) held by The Board of Regents of the University of Texas System expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/1709